Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Hepatology. 2010 Jun;51(6):1979–1987. doi: 10.1002/hep.23593

Table 1.

Characteristics of the participants

Category All (2589)* No Fatty Liver (2150)* Fatty Liver (439)* p-value#
Covariates
 Female (%) 51 44 53 0.0002
 Age (years) 51.0(10.6) 50.8(10.6) 52.3(10.7) 0.0015
 Drinks per week 3.0(3.5) 3.0(3.4) 3.1(3.9) 0.7619
 Physical Activity 37.4(6.8) 37.5(6.9) 36.9(6.4) 0.0256
 Smoking Category 0.1376
  Smoke Never (%) 49.7 (1287) 50.6 (1088) 45.3 (199)
  Smoke Former (%) 38.7 (1002) 37.9 (815) 42.6 (137)
  Smoke Current (%) 11.6 (300) 11.5 (247) 12.1 (53)
 Education Category 0.0028
  Education some High School (%) 1.6 (41) 1.5 (32) 2.5 (11)
  Education High School Graduate 21.3 (551) 20.7 (445) 24.3 (107)
  Education Some College (%) 29.7 (769) 29.0 (624) 32.9 (144)
  Education College Graduate (%) 47.4 (1227) 48.8 (1049) 40.3 (177)
 Menopause (women only) (%) 26.1 (676) 26.1 (561) 26.2 (115) 0.0623
 HRT (%) 11.9 (308) 11.8 (254) 12.5 (55) 0.1872
Fat related
 BMI (kg/m2) 27.6(5.3) 26.8(4.8) 31.4(5.8) <.0001
 Waist Circumference (cm) 96.5(14.3) 94.4(13.4) 106.4(14.1) <.0001
 Subcutaneous Adipose Tissue (cm3) 2847.7(1399.0) 2697.5(1327.1) 3583.4(1506.4) <.0001
 Visceral Adipose Tissue (cm3) 1749.5(1021.4) 1568.1(912.9) 2638.1(1059.6) <.0001
 BMI Category <.0001
  Normal weight (BMI<25) 34.0 (882) 38.9 (837) 10.3 (45)
  Overweight (25<=BMI<30) 39.5 (1022) 40.4(869) 34.9 (153)
  Obese (BMI>=30) 26.5 (685) 20.7 (444) 54.9 (241)
Glucose related
 Fasting Glucose (mg/dl) 99.1 (12.9) 97.1 (19.4) 108.7 (33.6) <.0001
 Diabetes Mellitus (%) 6.7 (173) 5.1 (110) 14.6 (64) <.0001
 IFG-Non-DM Only(%) 27.5 (712) 23.6 (507) 48.8 (214) <.0001
 HOMA-IR [Median (Q1–Q3)] 2.63 (2.11 – 3.54) 2.47 (2.05 – 3.21) 3.88 (2.95 – 5.39) <.0001
 log HOMA-IR 1.03 (0.47) 0.95 (0.43) 1.40 (0.51) <.0001
 Insulin resistance (%) 28.9(692) 21.6(425) 62.7(267) <.0001
 Adiponectin (μg/ml)** 9.8(6.0) 10.5(6.1) 7.0(4.8) <.0001
 Resistin [Median (Q1–Q3)] 13.40 (10.60 – 17.10) 13.25 (10.40 – 17.05) 14.20 (11.80 – 17.70) 0.0474
 log Resistin (ng/ml)** 2.62 (0.41) 2.61 (0.41) 2.67 (0.39) 0.1199
Lipid related
 Triglycerides (mg/dL) 103[71–155] 95[67–139] 157[110–217] <.0001
 HDL Cholesterol (mg/dl) 52.5(15.8) 54.0(15.7) 45.2(14.1) <.0001
 Total Cholesterol (mg/dL) 195.2(35.4) 194.6(35.0) 197.9(37.1) 0.1065
Blood pressure related
 SBP (mmHg) 121.1 (16.2) 120.0(16.1) 126.8(15.3) <.0001
 DBP (mmHg) 75.28(9.3) 74.7(9.1) 78.1 (9.5) <.0001
 Hypertension (%) 27.3 (707) 23.6 (507) 45.4 (199) <.0001
Syndrome related
 Metabolic Syndrome (%) 31.4 (813) 25.0 (538) 62.9 (276) <.0001

data in parentheses refers to the standard deviation for continuous traits and the number affected for dichotomous traits

*

represents mean (SD) or median(inter quartile range) or percent (number of individuals)

#

based on t-test or Wilcoxon Rank Sum Test or Chi squared

**

based on 857 individuals in offspring only, 157 with fatty liver and 700 without fatty liver

HRT: hormone replacement therapy

BMI: Body mass index

IFG: impaired fasting glucose

HOMA-IR: Homeostasis model assessment of insulin resistance

HDL: high density lipoprotein

SBP: systolic blood pressure